Welcome to BarramundiBarramundi is an investment company listed on the New Zealand Stock Exchange. We invest in small, growing Australian companies and seek to create shareholder value through growing our investment assets and paying dividends to shareholders.
The investment portfolio of Barramundi is managed by Fisher Funds Management Limited (“Fisher Funds” or the “Manager”), an investment manager with a track record of successfully investing in small company shares. The Barramundi portfolioPharmaxis published results from its Phase 3 Bronchitol drug trial for people suffering from Cystic Fibrosis. The results support the early and sustained improvement in lung function in Cystic Fibrosis patients seen in the first phase III study (CF301). Read more.
Getting InformationLatest NewsClick on the articles below to read more:
|
Current Share Price Information
* this table is live and is updated as trading occurs Weekly Price Chart - Barramundi Shares(BRM)
Weekly Price Chart - Barramundi Warrants (BRMWB)
Click here to view the Barramundi NAV v Share Price. |